A substantial proportion of microsatellite-unstable colon tumors carry TP53 mutations while not showing chromosomal instability

Genes Chromosomes and Cancer

Volumn 43, Issue 2, 2005, Pages 194-201

  Westra, Jantine L ^a   Boven, Ludolf G ^a   Van Der Vlies, Pieter ^a   Faber, Hendrika ^a   Sikkema, Birgit ^a   Schaapveld, Michael ^b   Dijkhuizen, Trijnie ^a   Hollema, Harry ^c   Buys, Charles H C M ^a   Plukker, John T M ^c   Kok, Klaas ^a   Hofstra, Robert M W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Integraal Kankercentrum Noord Nederland   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FORMALDEHYDE; PARAFFIN; PROTEIN P53;

ARTICLE; CANCER SCREENING; CHROMOSOMAL INSTABILITY; CHROMOSOME ANALYSIS; COLON TUMOR; CONTROLLED STUDY; DNA EXTRACTION; DNA HYBRIDIZATION; HUMAN; MICROSATELLITE INSTABILITY; MUTATION; PRIORITY JOURNAL;

CHROMOSOMES, ARTIFICIAL, BACTERIAL; COLONIC NEOPLASMS; GENES, P53; HUMANS; MICROSATELLITE REPEATS; MUTATION;

EID: 20244376754     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20148     Document Type: Article

References (35)

1. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B, de la Chapelle A. 1993. Clues to the pathogenesis of familial colorectal cancer. Science 260:812-816.
2. Agapova LS, Ilyinskaya GV, Turovets NA, Ivanov AV, Chumakov PM, Kopnin BP. 1996. Chromosome changes caused by alterations of p53 expression. Mutat Res 354:129-138.
3. Breivik J, Lothe RA, Meling GI, Rognum TO, Borresen-Dale A-L, Guadernack G. 1997. Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74:664-669.
4. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. 1998. A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257.
5. Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA. 2003. p53 Loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase. Haematologica 88:622-630.
6. Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C. 2002. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 62:1129-1133.
7. Campomenosi P, Assereto P, Bogliolo M, Fronza G, Abbondandolo A, Capasso A, Bellomo PF, Monaco R, Rapallo A, Sciutto A, Orecchia R, Geido E, Giaretti W. 1998. p53 Mutations and DNA ploidy in colorectal adenocarcinomas. Anal Cell Pathol 17:1-12.
8. Carder P, Wyllie AH, Purdie CA, Morris RG, White S, Piris J, Bird CC. 1993. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 8:1397-1401.
9. Clausen OP, Lothe RA, Borresen-Dale AL, De Angelis P, Chen Y, Rognum TO, Meling GI. 1998. Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas. Diagn Mol Pathol 7:215-223.
10. Curtis LJ, Georgiades IB, White S, Bird CC, Harrison DJ, Wyllie AH. 2000. Specific patterns of chromosomal abnormalities are associated with RER status in sporadic colorectal cancer. J Pathol 192:440-445.
11. De Angelis PM, Clausen OP, Schjolberg A, Stokke T 1999. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer 80:526-535.
12. De Angelis PM, Stokke T, Beigi M, Mjaland O, Clausen OP. 2001. Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer. Int J Colorectal Dis 16:38-45.
13. Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, Bodmer W, Tomlinson IP, Carter NP. 2004. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 64:4817-4825.
14. Duval A, Rolland S, Compaint A, Tubacher E, Iacopetta B, Thomas G, Hamelin R. 2001. Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers. Hum Mol Genet 10:513-518.
15. Elsaleh H, Powell B, McCaul K, Grieu F, Grant R, Joseph D, Iacopetta B. 2001. p53 Alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 7:1343-1349.
16. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
17. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, Carter NP. 2003. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36:361-374.
18. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. 1996. Abnormal centrosome amplification in the absence of p53. Science 271:1744-1747.
19. Goepfert TM, McCarthy M, Kittrell FS, Stephens C, Ullrich RL, Brinkley BR, Medina D. 2000. Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells. FASEB J 14:2221-2229.
20. He QJ, Zeng WF, Sham JS, Xie D, Yang XW, Lin HL, Zhan WH, Lin F, Zeng SD, Nie D, Ma LF, Li CJ, Lu S, Guan XY. 2003. Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. Cancer Genet Cytogenet 144:112-118.
21. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. 1993. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561.
22. Lengauer C, Kinzler KW, Vogelstein B. 1997. Genetic instability in colorectal cancers. Nature 386:623-627.
23. Leslie A, Pratt NR, Gillespie K, Sales M, Kernohan NM, Smith G, Wolf CR, Carey FA, Steele RJ. 2003. Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas. Cancer Res 63:4656-4661.
24. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
25. Lu X, Magrane G, Yin C, Louis DN, Gray J, Van Dyke T. 2001. Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability. Mol Cell Biol 21:6017-6030.
26. Murphy KL, Dennis AP, Rosen JM. 2000. A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model. FASEB J 14:2291-2302.
27. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. 2002. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607-614.
28. Rooney PH, Boonsong A, McKay JA, Marsh S, Stevenson DA, Murray GI, Curran S, Haites NE, Cassidy J, McLeod HL. 2001. Colorectal cancer genomics: evidence for multiple genotypes which influence survival. Br J Cancer 85:1492-1498.
29. Salahshor S, Kressner U, Pahlman L, Glimelius B, Lindmark G, Lindblom A. 1999. Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer 26:247-252.
30. Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, Leppert MF, Slattery ML. 2001. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 158:1517-1524.
31. Samowitz WS, Curtin K, Ma KN, Schaffer D, Leppert MF, Slattery ML. 2002. Prognostic significance of p53 mutations in colon cancer at the population level. Int J Cancer 99:597-602.
32. Thibodeau SN, Bren G, Schaid D. 1993. Microsatellite instability in cancer of the proximal colon. Science 260:816-819.
33. Toft NJ, Curtis LJ, Sansom OJ, Leitch AL, Wyllie AH, te Riele H, Arends MJ, Clarke AR. 2002. Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background. Oncogene 21:6299-6306.
34. Westra JL, Schaapveld M, de Boer JP, Kraak MMJ, de Jong D, ter Elst A, Hollema H, Mulder NH, Buys CHCM, Hofstra RMW, Plukker JTM. Presence or absence of a TP53 mutation better predicts disease-free survival in adjuvantly treated stage III colon cancer patients than microsatellite instability status. (Submitted.)
35. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.